Psychomotor Agitation
22
0
1
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
41%
9 trials in Phase 3/4
38%
6 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (22)
ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
Objective Assessment of Behavioral Associations of Patients With Dementia
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
Clinical Trial of Peer Support in the ED (PCORI)
A Study of Staccato Loxapine (ADASUVE®) for Inhalation
Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?
Nicotine Replacement Therapy in the Intensive Care Unit
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia
Actigraphic Analysis of Treatment Response
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation
Haloperidol vs. Valproate in Agitation
Alzheimer's in Long-Term Care--Treatment for Agitation
The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia
Escitalopram Treatment of Patients With Agitated Dementia
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation
Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)